bluebird bio Inc. (NASDAQ: BLUE)
$8.4900
-0.0100 ( +2.30% ) 0.3K
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Market Data
Open
$8.4900
Previous close
$8.5000
Volume
0.3K
Market cap
$82.64M
Day range
$8.1700 - $8.2990
52 week range
$5.8000 - $38.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 23, 2024 |
8-k | 8K-related | 17 | Aug 14, 2024 |
nt | Quarterly Reports | 1 | Aug 14, 2024 |
8-k | 8K-related | 14 | Jul 11, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
8-k | 8K-related | 13 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 24, 2024 |
3 | Insider transactions | 2 | Jun 24, 2024 |
3 | Insider transactions | 2 | Jun 13, 2024 |
4 | Insider transactions | 2 | Jun 04, 2024 |